NO974270L - Insulinderivater - Google Patents

Insulinderivater

Info

Publication number: NO974270L
Authority: NO; Norway
Prior art keywords: insulin derivatives; group; chain; amino acid; terminal amino
Prior art date: 1995-03-17

Application number

NO974270A

Other languages

English (en)

Norwegian (no)

Other versions

NO974270D0 (no

Inventor

Jan Markussen

Ib Jonassen

Svend Havelund

Jakob Brandt

Peter Kurtzhals

Peter Hertz Hansen

Niels Christian Kaarsholm

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-17

Filing date

1997-09-16

Publication date

1997-11-14

1997-09-16 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1997-09-16 Publication of NO974270D0 publication Critical patent/NO974270D0/no

1997-11-14 Publication of NO974270L publication Critical patent/NO974270L/no

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 2
125000001433 C-terminal amino-acid group Chemical group 0.000 abstract 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
230000005923 long-lasting effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO974270A 1995-03-17 1997-09-16 Insulinderivater NO974270L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK27695		1995-03-17
PCT/DK1996/000107 WO1996029344A1 (en)	1995-03-17	1996-03-18	Insulin derivatives

Publications (2)

Publication Number	Publication Date
NO974270D0 NO974270D0 (no)	1997-09-16
NO974270L true NO974270L (no)	1997-11-14

Family

ID=8091725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO974270A NO974270L (no)	1995-03-17	1997-09-16	Insulinderivater

Country Status (14)

Country	Link
EP (1)	EP0871665B1 (cs)
JP (1)	JP3872105B2 (cs)
KR (1)	KR19980703039A (cs)
CN (1)	CN1196061A (cs)
AT (1)	ATE245659T1 (cs)
AU (1)	AU720966B2 (cs)
BR (1)	BR9607647A (cs)
CA (1)	CA2215694A1 (cs)
CZ (1)	CZ289343B6 (cs)
DE (1)	DE69629210T2 (cs)
HU (1)	HUP9800523A3 (cs)
NO (1)	NO974270L (cs)
PL (1)	PL183698B1 (cs)
WO (1)	WO1996029344A1 (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5693609A (en) *	1994-11-17	1997-12-02	Eli Lilly And Company	Acylated insulin analogs
US6451970B1 (en) *	1996-02-21	2002-09-17	Novo Nordisk A/S	Peptide derivatives
US7235627B2 (en)	1996-08-30	2007-06-26	Novo Nordisk A/S	Derivatives of GLP-1 analogs
US6268343B1 (en)	1996-08-30	2001-07-31	Novo Nordisk A/S	Derivatives of GLP-1 analogs
US6458924B2 (en)	1996-08-30	2002-10-01	Novo Nordisk A/S	Derivatives of GLP-1 analogs
JP2001521004A (ja)	1997-10-24	2001-11-06	イーライ・リリー・アンド・カンパニー	脂肪酸−アシル化インスリン類似体
CO4970787A1 (es)	1997-12-23	2000-11-07	Lilly Co Eli	Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
EP1051432B1 (en) *	1998-12-08	2007-01-24	Biovation Limited	Method for reducing immunogenicity of proteins
TWI242000B (en) *	1998-12-10	2005-10-21	Univ Southern California	Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
WO2003094956A1 (en)	2002-05-07	2003-11-20	Novo Nordisk A/S	Soluble formulations comprising monomeric insulin and acylated insulin
CN1247616C (zh) *	2002-07-19	2006-03-29	上海中科生龙达生物技术（集团）有限公司	新的单体胰岛素，药物组合物及其制法
EP2107069B1 (en)	2003-08-05	2013-01-16	Novo Nordisk A/S	Novel insulin derivatives
EP1687428A1 (en)	2003-11-14	2006-08-09	Novo Nordisk A/S	Processes for making acylated insulin
ES2642214T3 (es)	2004-01-21	2017-11-15	Novo Nordisk Health Care Ag	Conjugación de péptidos mediante transglutaminasa
PL2060266T3 (pl)	2004-03-17	2012-01-31	7Tm Pharma As	Selektywni agoniści PP2-36 receptora Y4 do interwencji terapeutycznych
EA011860B1 (ru)	2004-03-17	2009-06-30	7ТиЭм ФАРМА А/С	Селективные агонисты рецептора y2 для терапевтического воздействия
ES2438145T3 (es)	2005-02-02	2014-01-16	Novo Nordisk A/S	Nuevos derivados de insulina
JP5410020B2 (ja)	2005-02-02	2014-02-05	ノヴォノルディスクアー／エス	インスリン誘導体
US20090074882A1 (en)	2005-12-28	2009-03-19	Novo Nordisk A/S	Insulin compositions and method of making a composition
JP5202338B2 (ja)	2006-02-27	2013-06-05	ノボ・ノルデイスク・エー／エス	新規インシュリン誘導体
BRPI0712041A2 (pt) *	2006-05-09	2011-12-27	Novo Nordisk As	derivado de insulina
JP5550338B2 (ja)	2006-07-31	2014-07-16	ノボ・ノルデイスク・エー／エス	ペグ化持続型インスリン
HUE029512T2 (en)	2006-09-22	2017-03-28	Novo Nordisk As	Protease Resistant Insulin Analogs
JP5496082B2 (ja)	2007-04-30	2014-05-21	ノボ・ノルデイスク・エー／エス	タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP5552046B2 (ja)	2007-06-13	2014-07-16	ノボ・ノルデイスク・エー／エス	インスリン誘導体を含有する薬学的製剤
EP2058330A1 (en) *	2007-11-08	2009-05-13	Novo Nordisk A/S	Insulin derivative
US8710000B2 (en)	2007-11-08	2014-04-29	Novo Nordisk A/S	Insulin derivative
JP5762001B2 (ja) *	2008-03-14	2015-08-12	ノボ・ノルデイスク・エー／エス	プロテアーゼ安定化インスリンアナログ
WO2009115469A1 (en)	2008-03-18	2009-09-24	Novo Nordisk A/S	Protease stabilized, acylated insulin analogues
KR20110085985A (ko)	2008-10-30	2011-07-27	노보 노르디스크 에이/에스	하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
BR112013010345A2 (pt)	2010-10-27	2017-07-25	Novo Nordisk As	tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
CA2870313A1 (en)	2012-04-11	2013-10-17	Novo Nordisk A/S	Insulin formulations
JP2016519127A (ja)	2013-04-30	2016-06-30	ノヴォノルディスクアー／エス	新規投与レジメン
AU2014333979B2 (en)	2013-10-07	2018-02-15	Novo Nordisk A/S	Novel derivative of an insulin analogue
AR099569A1 (es)	2014-02-28	2016-08-03	Novo Nordisk As	Derivados de insulina y los usos médicos de estos
ES2886837T3 (es)	2016-12-16	2021-12-21	Novo Nordisk As	Composiciones farmacéuticas que contienen insulina
HUE066356T2 (hu)	2017-08-24	2024-07-28	Novo Nordisk As	GLP-1 készítmények és alkalmazásaik
US10335464B1 (en)	2018-06-26	2019-07-02	Novo Nordisk A/S	Device for titrating basal insulin
WO2020120477A1 (en)	2018-12-11	2020-06-18	Sanofi	Insulin analogs having reduced insulin receptor binding affinity
US12343383B2 (en)	2019-07-12	2025-07-01	Novo Nordisk A/S	High concentration insulin formulation
PE20221575A1 (es)	2020-02-18	2022-10-06	Novo Nordisk As	Formulaciones farmaceuticas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3844211A1 (de) *	1988-12-29	1990-07-05	Hoechst Ag	Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK155690D0 (da) *	1990-06-28	1990-06-28	Novo Nordisk As	Nye peptider
SI0792290T1 (en) *	1993-09-17	2001-12-31	Novo Nordisk As	Acylated insulin

1996
- 1996-03-18 EP EP96905764A patent/EP0871665B1/en not_active Expired - Lifetime
- 1996-03-18 AT AT96905764T patent/ATE245659T1/de not_active IP Right Cessation
- 1996-03-18 CN CN96193362A patent/CN1196061A/zh active Pending
- 1996-03-18 PL PL96322299A patent/PL183698B1/pl unknown
- 1996-03-18 CA CA002215694A patent/CA2215694A1/en not_active Abandoned
- 1996-03-18 DE DE69629210T patent/DE69629210T2/de not_active Expired - Lifetime
- 1996-03-18 WO PCT/DK1996/000107 patent/WO1996029344A1/en not_active Ceased
- 1996-03-18 CZ CZ19972899A patent/CZ289343B6/cs not_active IP Right Cessation
- 1996-03-18 AU AU49396/96A patent/AU720966B2/en not_active Ceased
- 1996-03-18 HU HU9800523A patent/HUP9800523A3/hu unknown
- 1996-03-18 KR KR1019970706447A patent/KR19980703039A/ko not_active Ceased
- 1996-03-18 JP JP52799596A patent/JP3872105B2/ja not_active Expired - Fee Related
- 1996-03-18 BR BR9607647A patent/BR9607647A/pt not_active Application Discontinuation
1997
- 1997-09-16 NO NO974270A patent/NO974270L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1996029344A1 (en)	1996-09-26
JP3872105B2 (ja)	2007-01-24
PL183698B1 (pl)	2002-06-28
CZ289343B6 (cs)	2002-01-16
MX9707056A (es)	1997-11-29
DE69629210D1 (de)	2003-08-28
DE69629210T2 (de)	2004-04-22
HUP9800523A3 (en)	1998-09-28
AU720966B2 (en)	2000-06-22
CA2215694A1 (en)	1996-09-26
ATE245659T1 (de)	2003-08-15
EP0871665A1 (en)	1998-10-21
KR19980703039A (ko)	1998-09-05
PL322299A1 (en)	1998-01-19
EP0871665B1 (en)	2003-07-23
NO974270D0 (no)	1997-09-16
AU4939696A (en)	1996-10-08
BR9607647A (pt)	1999-04-06
HUP9800523A2 (hu)	1998-06-29
CN1196061A (zh)	1998-10-14
JPH11502110A (ja)	1999-02-23
CZ289997A3 (cs)	1998-01-14

Legal Events

Date	Code	Title	Description
2002-10-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE245659T1 (de)	2003-08-15	Insulinabkömmlinge
NO974269L (no)	1997-11-14	Lipofile peptidhormonderivater
DE69432758D1 (en)	2003-07-03	Therapeutisch wirksame peptidderivate
DE69728149D1 (de)	2004-04-22	Modifizierte liganden für den tie-2-rezeptor
HUP0100928A2 (hu)	2001-08-28	Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
NO974514L (no)	1997-11-27	Syntetisk HPV6/11 hybrid L1 DNA som koder for humant papillomavirus Type 11 L1-protein
ATE245435T1 (de)	2003-08-15	Totalsynthese des amino hip analogen von didemnin a
BR9609393A (pt)	1999-12-21	Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos.
DK0659084T3 (da)	1997-05-05	Medicinske præparater indeholdende N-methylerede cycliske undecapeptider
ATE364079T1 (de)	2007-06-15	Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
EP1313440A4 (en)	2004-07-14	DENTAL PREPARATIONS CONTAIN PEPTIDES THAT PROMOTE BONE GROWTH
MX9709398A (es)	1998-07-31	N-aril-1,2,4-triazolin-5-onas.
DE3780000D1 (de)	1992-07-30	Peptidverbindungen.
SG129211A1 (en)	2007-02-26	Therapeutic molecules
FR2703054B1 (fr)	1995-06-16	Promoteur vegetal inductible au stress et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur.
CO4700528A1 (es)	1998-12-29	Peptidos de somatostatina
ATE125548T1 (de)	1995-08-15	Peptide.
DE69834929D1 (de)	2006-07-27	Verwendung eines organspezifischen ernährungmittels
ATE195147T1 (de)	2000-08-15	Aminosäuren konjugaten
MX9206732A (es)	1993-05-01	Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas de tierra.
DK0579785T3 (da)	1996-10-28	Substituerede benzhydrylaminer som tlslutningsmolekyler til fastfasepeptidsyntese
IT1277391B1 (it)	1997-11-10	Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita
NO981051L (no)	1998-05-11	Peptidderivater
SI1401871T1 (cs)	2005-08-31
MX9802268A (es)	1998-08-30	Nuevos derivados de la substancia pf1022 de ciclodepsipeptido.